• OPEN AN ACCOUNT
Indian Indices
Sensex
82,310.79 3.42
( 0.00%)
Global Indices
Nasdaq
49,393.18 294.94
(0.60%)
Dow Jones
6,933.34 36.72
(0.53%)
Hang Seng
53,761.00 986.36
(1.87%)
Nikkei 225
10,161.37 23.28
(0.23%)
Forex
USD-INR
91.49 0.49
(0.54%)
EUR-INR
107.13 0.65
(0.61%)
GBP-INR
122.87 0.50
(0.41%)
JPY-INR
0.58 0.00
(0.49%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
140.8744507
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
0
15424.22
EPS(TTM)
Face Value()
Div & Yield %
0
1
0.52
 

MRF consolidated net profit rises 11.67% in the September 2025 quarter
Nov 14,2025
Net profit of MRF rose 11.67% to Rs 525.64 crore in the quarter ended September 2025 as against Rs 470.70 crore during the previous quarter ended September 2024. Sales rose 7.23% to Rs 7378.72 crore in the quarter ended September 2025 as against Rs 6881.09 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales7378.726881.09 7
OPM %15.2614.70 -
PBDT1143.771040.91 10
PBT698.66631.18 11
NP525.64470.70 12